TOCSIN SCIENCES
Business purpose.
Le développement de méthodologies issues de la neuroscience pour faciliter la sensibilisation des personnes aux pratiques de vigilance nécessaires dans des domaines comme la cybersécurité, la sécurité au travail, la sécurité routière et plus généralement les activités humaines qui présentent des risques pour les personnes ou les organisations.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 19 Nov 2020
- Share capital
- 5,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 2
Establishments
-
89189557500019 92150 SURESNES
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
72 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (5.9 years)
- 11.8 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Legal notices
-
Amendment 30 Jan 2024
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- transmission universelle du patrimoine.
BODACC B n 20240020, annonce n 2972 · Proof of publication (PDF)
-
Amendment 27 Oct 2023
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- transfert du siège social.
BODACC B n 20230208, annonce n 2133 · Proof of publication (PDF)
-
Incorporation 15 Dec 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE NANTERRE
BODACC A n 20200243, annonce n 3257 · Proof of publication (PDF)
Filings and accounts
- Formality 27 Jan 2024
Change history
- capital (empty) → 5000.00 3 Oct 2026
- registered_address (empty) → 30 Boulevard Bellerive 92500 Rueil-Malmaison 1 Oct 2026